Anogenital cutaneous Crohn's disease: effective treatment with interleukin-23 p19 inhibition in an under-recognized clinical entity. Colwill M, Spencer A, Honap S. J Crohns Colitis 2026;20:jjag047.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Colwill M, Spencer A, Honap S. Anogenital cutaneous Crohn's disease: effective treatment with interleukin-23 p19 inhibition in an under-recognized clinical entity. J Crohns Colitis 2026;20:jjag047.
PMID: 42036104